Moreover, because of the lack of indications about the expression and clinical significance of IGFBP2 and anti-IGFBP2 antibodies in other pediatric soft tissue sarcomas, a wider analysis is warranted to unveil a role as differential diagnostic biomarkers between different types of pediatric malignancies. Here, IGFBP2 is linked to soft tissue sarcoma.